Bicara Therapeutics Inc. Common Stock
Rachunek Zysków i Strat
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
| Rok finansowy |
2023 |
2023 |
2023 |
2023 |
2024 |
2024 |
2024 |
2024 |
2025 |
| Kwartał |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
| Data |
2023-03-31 |
2023-06-30 |
2023-09-30 |
2023-12-31 |
2024-03-31 |
2024-06-30 |
2024-09-30 |
2024-12-31 |
2025-03-31 |
| Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Przychód Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
| Marża brutto |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
| Koszty i Wydatki (mln) |
8 |
8 |
10 |
14 |
18 |
18 |
21 |
27 |
0 |
| EBIT (mln) |
-8 |
-8 |
-10 |
-14 |
-18 |
-18 |
-21 |
-27 |
-42 |
| EBIT Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
110.7% |
110.7% |
116.5% |
94.6% |
137.9% |
| EBIT (%) |
None |
None |
None |
None |
None |
None |
None |
None |
None |
| Przychody fiansowe (mln) |
0 |
0 |
0 |
1 |
0 |
0 |
3 |
6 |
5 |
| Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Amortyzacja (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EBITDA (mln) |
-8 |
-8 |
-10 |
-26 |
-18 |
-18 |
-21 |
-27 |
-42 |
| EBITDA(%) |
None |
None |
None |
None |
None |
None |
None |
None |
None |
| NOPLAT (mln) |
-8 |
-8 |
-23 |
-12 |
-15 |
-15 |
-17 |
-21 |
-37 |
| Podatek (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-0 |
| Zysk Netto (mln) |
-8 |
-8 |
-23 |
-12 |
-15 |
-15 |
-17 |
-21 |
-37 |
| Zysk netto Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
77.0% |
77.0% |
-23.48% |
68.5% |
149.3% |
| Zysk netto (%) |
None |
None |
None |
None |
None |
None |
None |
None |
None |
| EPS |
-0.15 |
-0.15 |
-0.42 |
-0.23 |
-0.27 |
-0.27 |
-0.32 |
-0.19 |
-0.68 |
| EPS (rozwodnione) |
-0.15 |
-0.15 |
-0.42 |
-0.23 |
-0.27 |
-0.27 |
-0.32 |
-0.19 |
-0.68 |
| Ilośc akcji (mln) |
55 |
55 |
54 |
53 |
54 |
54 |
54 |
111 |
54 |
| Ważona ilośc akcji (mln) |
55 |
55 |
54 |
53 |
54 |
54 |
54 |
111 |
54 |
| Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |